n-Lorem Foundation
Non-Profit & Charitable Organizations · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2888 Loker Ave E Ste 110, Carlsbad, Cali...Phone Number
(760) 552-7113Website
www.nlorem.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About n-Lorem Foundation
n-Lorem is dedicated to providing hope and potential help to nano-rare patients by offering experimental antisense oligonucleotide (ASO) medicines at no cost for life. The organization utilizes a mutation-driven approach to target the unique genetic causes of diseases affecting patients with rare gene mutations. With over 30 years of expertise in ASO technology, n-Lorem aims to bridge genomic discovery to personalized medicine, ensuring high-quality treatment for each patient. Their mission emphasizes patient empowerment and the sharing of knowledge to advance the understanding of rare diseases.Explore more
n-Lorem Foundation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is n-Lorem Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
n-Lorem Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when n-Lorem Foundation launches new products
Congratulate Masked Content for being promoted to Masked Content at n-Lorem Foundation
Website visits: Recent activity has been detected on your website
Click to see if n-Lorem Foundation had a recent Job posting/layoffs
Check out if n-Lorem Foundation is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on n-Lorem Foundation recently announced quarterly report
Funding: Get notified immidiatlly once n-Lorem Foundation has new funding data
Check if n-Lorem Foundation has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined n-Lorem Foundation as Masked Content
Find 3 more new buyers
Compare Similar Companies to n-Lorem Foundation
Compare insights from companies similar to n-Lorem Foundation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
n-Lorem Foundation
<$5M
11-50
Private
-
2020
AW
Amy WillifordVice President, Foundation Development & External Relations
Company Profile Activity
Activity Insights
n-Lorem Foundation is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
n-Lorem Foundation is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about n-Lorem Foundation.
n-Lorem Foundation Tech Stack
A closer look at the technologies used by n-Lorem Foundation
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Person-Based
Events, Search, Medical Research
Event
Events
n-Lorem Foundation News & Media
Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine approaches for patients across the world. Servier strengthens its commitment to rare...n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases
SAN DIEGO and GENEVA, Jan. 12, 2026 /PRNewswire/ -- The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to n-Lorem's antisense oligonucleotide (ASO) therapies for patients with rare genetic diseases. The collaboration...PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic modelsn-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients
SAN DIEGO--(BUSINESS WIRE)-- #ASO--This work provides critical insights into the role of JIP3 in neurodevelopmental disorders.
Read more news
Top Non-Profit & Charitable Organizations Companies
See more top companies
Frequently Asked Questions Regarding n-Lorem Foundation
Sign Up For FreeTo access detailed company insights
n-Lorem is dedicated to providing hope and potential help to nano-rare patients by offering experimental antisense oligonucleotide (ASO) medicines at no cost for life. The organization utilizes a mutation-driven approach to target the unique genetic causes of diseases affecting patients with rare gene mutations. With over 30 years of expertise in A... Read More
